Kuno, Shimpei
Nakano, Yusuke
Suzuki, Yasushi
Ando, Hirohiko
Suzuki, Wataru
Takahashi, Hiroshi
Amano, Tetsuya
Article History
Received: 3 April 2023
Accepted: 9 October 2023
First Online: 11 October 2023
Competing interests
: Y.N. reported receiving lecture fees from Ono Pharma Co., Ltd., AstraZeneca, Otsuka Pharma Co., Ltd., Nihon Medi-Physics Co., Ltd., and Novartis Pharma Co., Ltd. T.A. reported receiving lecture fees from Astellas Pharma Co., Ltd., AstraZeneca, Daiichi Sankyo, Otsuka Pharma Co., Ltd., Nihon Medi-Physics Co., Ltd., and Novartis Pharma Co., Ltd. Other Authors do not have any conflict of interest.